Mandatory notification of acquisition of shares by primary insider
Nykode Therapeutics ASA (NYKD) · publisert 22. februar 2022 kl. 12:30 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Martin Nicklasson | – | Kjøp | 10 000 | 42 NOK | 22. februar 2022 | NO0010714785 | MERK – Euronext Growth Oslo |
Vedlegg
- Attachment 220222.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, February 22, 2022 - Primary insider Martin Nicklasson, Chairman of the Board of Nykode Therapeutics AS, has today acquired 10,000 shares in Nykode Therapeutics AS at a price of NOK 42.00 per share. Following the transaction, Martin Nicklasson holds 22,000 shares in Nykode Therapeutics AS.
Please see further details in the attached document.